vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and TELOS CORP (TLS). Click either name above to swap in a different company.
TELOS CORP is the larger business by last-quarter revenue ($46.8M vs $44.5M, roughly 1.1× Cronos Group Inc.). Cronos Group Inc. runs the higher net margin — -4.1% vs -34.9%, a 30.8% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 47.0%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $8.0M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 25.7%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.
CRON vs TLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $46.8M |
| Net Profit | $-1.8M | $-16.3M |
| Gross Margin | 36.4% | 35.0% |
| Operating Margin | -16.8% | -39.6% |
| Net Margin | -4.1% | -34.9% |
| Revenue YoY | 47.0% | 77.4% |
| Net Profit YoY | -104.2% | -74.8% |
| EPS (diluted) | $-0.01 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $46.8M | ||
| Q3 25 | $36.3M | $51.4M | ||
| Q2 25 | $33.5M | $36.0M | ||
| Q1 25 | $32.3M | $30.6M | ||
| Q4 24 | $30.3M | $26.4M | ||
| Q3 24 | $34.3M | $23.8M | ||
| Q2 24 | $27.8M | $28.5M | ||
| Q1 24 | $25.3M | $29.6M |
| Q4 25 | $-1.8M | $-16.3M | ||
| Q3 25 | $26.0M | $-2.1M | ||
| Q2 25 | $-39.7M | $-9.5M | ||
| Q1 25 | $6.1M | $-8.6M | ||
| Q4 24 | $43.7M | $-9.3M | ||
| Q3 24 | $8.3M | $-28.1M | ||
| Q2 24 | $-8.8M | $-7.8M | ||
| Q1 24 | $-2.2M | $-7.4M |
| Q4 25 | 36.4% | 35.0% | ||
| Q3 25 | 50.4% | 39.9% | ||
| Q2 25 | 43.4% | 33.2% | ||
| Q1 25 | 42.6% | 39.8% | ||
| Q4 24 | 35.7% | 40.3% | ||
| Q3 24 | 10.5% | 13.2% | ||
| Q2 24 | 22.7% | 34.1% | ||
| Q1 24 | 17.7% | 37.0% |
| Q4 25 | -16.8% | -39.6% | ||
| Q3 25 | -1.4% | -4.8% | ||
| Q2 25 | -15.9% | -27.5% | ||
| Q1 25 | -12.6% | -29.5% | ||
| Q4 24 | -37.5% | -37.6% | ||
| Q3 24 | -98.2% | -121.4% | ||
| Q2 24 | -56.1% | -30.3% | ||
| Q1 24 | -63.1% | -28.5% |
| Q4 25 | -4.1% | -34.9% | ||
| Q3 25 | 71.4% | -4.1% | ||
| Q2 25 | -118.7% | -26.5% | ||
| Q1 25 | 19.0% | -28.1% | ||
| Q4 24 | 144.3% | -35.4% | ||
| Q3 24 | 24.4% | -118.0% | ||
| Q2 24 | -31.5% | -27.2% | ||
| Q1 24 | -8.9% | -24.9% |
| Q4 25 | $-0.01 | $-0.22 | ||
| Q3 25 | $0.07 | $-0.03 | ||
| Q2 25 | $-0.10 | $-0.13 | ||
| Q1 25 | $0.02 | $-0.12 | ||
| Q4 24 | $0.12 | $-0.13 | ||
| Q3 24 | $0.02 | $-0.39 | ||
| Q2 24 | $-0.02 | $-0.11 | ||
| Q1 24 | $-0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $53.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $96.0M |
| Total Assets | $1.2B | $139.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $53.2M | ||
| Q3 25 | $824.2M | $59.0M | ||
| Q2 25 | $834.4M | $57.0M | ||
| Q1 25 | $837.8M | $57.8M | ||
| Q4 24 | $858.8M | $54.6M | ||
| Q3 24 | $862.0M | $69.8M | ||
| Q2 24 | $848.2M | $80.1M | ||
| Q1 24 | $855.1M | $93.9M |
| Q4 25 | $1.1B | $96.0M | ||
| Q3 25 | $1.1B | $119.7M | ||
| Q2 25 | $1.1B | $118.4M | ||
| Q1 25 | $1.1B | $126.1M | ||
| Q4 24 | $1.1B | $127.1M | ||
| Q3 24 | $1.1B | $129.5M | ||
| Q2 24 | $1.1B | $149.1M | ||
| Q1 24 | $1.1B | $154.4M |
| Q4 25 | $1.2B | $139.9M | ||
| Q3 25 | $1.2B | $164.3M | ||
| Q2 25 | $1.2B | $165.0M | ||
| Q1 25 | $1.2B | $158.1M | ||
| Q4 24 | $1.2B | $158.2M | ||
| Q3 24 | $1.2B | $166.3M | ||
| Q2 24 | $1.1B | $182.4M | ||
| Q1 24 | $1.1B | $195.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $8.0M |
| Free Cash FlowOCF − Capex | $9.7M | $8.0M |
| FCF MarginFCF / Revenue | 21.8% | 17.0% |
| Capex IntensityCapex / Revenue | 4.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $29.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $8.0M | ||
| Q3 25 | $13.3M | $9.1M | ||
| Q2 25 | $2.8M | $7.0M | ||
| Q1 25 | $-2.1M | $6.1M | ||
| Q4 24 | $7.7M | $-10.5M | ||
| Q3 24 | $11.6M | $-7.1M | ||
| Q2 24 | $1.7M | $-8.0M | ||
| Q1 24 | $-2.2M | $-350.0K |
| Q4 25 | $9.7M | $8.0M | ||
| Q3 25 | $8.8M | $8.7M | ||
| Q2 25 | $-1.0M | $6.8M | ||
| Q1 25 | $-17.4M | $6.0M | ||
| Q4 24 | $4.2M | $-12.4M | ||
| Q3 24 | $5.2M | $-7.1M | ||
| Q2 24 | $1.0M | $-8.2M | ||
| Q1 24 | $-3.9M | $-447.0K |
| Q4 25 | 21.8% | 17.0% | ||
| Q3 25 | 24.3% | 16.9% | ||
| Q2 25 | -3.0% | 19.0% | ||
| Q1 25 | -53.8% | 19.5% | ||
| Q4 24 | 13.8% | -47.0% | ||
| Q3 24 | 15.1% | -30.0% | ||
| Q2 24 | 3.7% | -28.9% | ||
| Q1 24 | -15.5% | -1.5% |
| Q4 25 | 4.8% | 0.1% | ||
| Q3 25 | 12.3% | 0.9% | ||
| Q2 25 | 11.5% | 0.4% | ||
| Q1 25 | 47.3% | 0.4% | ||
| Q4 24 | 11.7% | 7.1% | ||
| Q3 24 | 18.7% | 0.2% | ||
| Q2 24 | 2.6% | 0.8% | ||
| Q1 24 | 6.8% | 0.3% |
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
TLS
| Security Solutions Segment | $44.8M | 96% |
| Secure Networks Segment | $1.9M | 4% |
